
    
      Patients randomly assigned to chemotherapy alone received the second course of induction
      chemotherapy as soon as clinically indicated; patients randomly assigned to receive
      chemotherapy plus sequential lestaurtinib had lestaurtinib withheld for 3 days (72 hours)
      before the start of the second 5-day course of chemotherapy and resumed lestaurtinib
      treatment 2 days (48 hours) after the final administration of the second course of
      chemotherapy.
    
  